Pharmaceutical / Drug Definition :
Decreases platelet aggregation by binding to platelet-receptor glycoprotein, preventing binding of fibrinogen to platelets, which causes thrombus formation
FDA Label Requirements and Exceptions
Eptifibatide
FDA Import Information
Eptifibatide
FDA Detentions
Eptifibatide (Eptifibatide Entry Refusal)
General U.S. Food and Drug Administration Guidelines for:
- Manufacturers Eptifibatide (Eptifibatide Suppliers)
- Processors Eptifibatide
- Repackers Eptifibatide
- Relabelers Eptifibatide
- Exporters Eptifibatide
- Importers Eptifibatide
For more information about Eptifibatide, simply click below:
U.S. FDA Regulations:
U.S. FDA Regulation: 21 C.F.R. Part 207
Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.
